Herantis Pharma is a startup based in Finland, 6 tracked investors.
Herantis Pharma is a company founded in 2008 headquartered in Finland. Brouky records 6 investors associated with the company.
Herantis Pharma is a clinical-stage biotechnology company developing protein- and peptide-based therapeutics, notably a CDNF (cerebral dopamine neurotrophic factor) program for Parkinson’s disease and other neurodegenerative and ophthalmic indications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.